Keyword Connections

bladder cancer

Journals

16

1 Nature communications

2 Scientific reports

3 Urology

4 journal of clinical medicine

5 colloids and surfaces b, biointerfaces

6 clinical therapeutics

7 urologia

8 International journal of surgery (London, England)

9 Journal of cancer research and clinical oncology

10 cancer cell international

11 faseb journal : official publication of the federation of american societies for experimental biology

12 european urology oncology

13 parasitology

14 Diagnostics (Basel, Switzerland)

15 molecular cancer

16 progres en urologie : journal de l'association francaise d'urologie et de la societe francaise d'urologie

Research Groups

0

No Research Group Connected

Bibliographies

97

1 Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes.

2 Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes.

3 Structure and function of the Orc1 BAH-nucleosome complex.

4 [Orthotopic neobladder reconstruction for bladder cancer: robotic-assisted versus open-radical cystectomy for perioperative outcomes, functional results and quality of life].

5 Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis.

6 CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.

7 Urinary diversion disparity following radical cystectomy for bladder cancer in the Hispanic population.

8 miR-190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma.

9 Bladder cancer genomics.

10 THE TOP 100 MOST CITED MANUSCRIPTS IN BLADDER CANCER: A BIBLIOMETRIC ANALYSIS (Review article).

11 Identification of a potentially functional circRNA-miRNA-mRNA regulatory network for investigating pathogenesis and providing possible biomarkers of bladder cancer.

12 Urban geochemical changes and pollution with potentially harmful elements in seven Russian cities.

13 Schistosomiasis then and now: what has changed in the last 100 years?

14 Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays.

15 current and innovative approaches in the treatment of non-muscle invasive bladder cancer: the role of transurethral resection of bladder tumor and organoids

16 transurethral en bloc resection of bladder tumors

17 collision metastasis of prostatic adenocarcinoma and urothelial carcinoma of the bladder

18 knockdown of cdca8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells

19 transfusion therapy in the radical surgical treatment of patients with urinary bladder and prostate cancers

20 a systematic experimental evaluation of microrna markers of human bladder cancer

21 is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: a prospective study

22 pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?

23 atg7 overexpression is crucial for tumorigenic growth of bladder cancer in vitro and in vivo by targeting the ets2/mirna196b/foxo1/p27 axis

24 ruguo key genes and tumor driving factors identification of bladder cancer based on the rna-seq profile

25 molecular markers of bladder cancer: from the particular to the general

26 early removal of nasogastric tube is beneficial for patients undergoing radical cystectomy with urinary diversion

27 pattern of management of urologic cancer in saudi arabia

28 medical image of the week: bronchial clot removal via cryotherapy

29 a pilot study on the potential of rna-associated to urinary vesicles as a suitable non-invasive source for diagnostic purposes in bladder cancer

30 the danish lung cancer registry

31 Differential Protein Expression Patterns of HOXA13 and HOXB13 Are Associated with Bladder Cancer Progression.

32 Biomimetic Nanoparticles Based on Tumor Cell Membrane Co-loaded with Vitamin E and Doxorubicin for Targeted Synergistic Treatment of Bladder Cancer.

33 Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells

34 Severe acute myocardial infarction and peripheral thrombosis in patient with bladder cancer

35 Chemosensitizing effect of cernumidine extracted from Solanum cernuum Vell. on bladder cancer cells in vitro.

36 The Cost to Medicare of Bladder Cancer Care.

37 Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.

38 METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.

39 Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

40 Development of a GIS-based indicator for environmental pesticide exposure and its application to a Belgian case-control study on bladder cancer.

41 A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.

42 [Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer].

43 Robotic versus open radical cystectomy for bladder cancer in adults.

44 Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population.

45 [Changes in gallbladder cancer mortality and hospital discharges due to preventive cholecystectomy in Chile].

46 Re: Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes: C. Gan, S. Amery, K. Chatterton, M. S. Khan, K. Thomas and T. O'Brien J Urol 2016; 195: 1697–1703.

47 Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.

48 Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

49 The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.

50 Comparison of Different Treatment Schedules of Mitomycin C Intravesical Instillation in High-Risk Superficial Bladder Cancer Patients.

51 Commentary on "Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer." Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D, Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, Garcia -Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR

52 PER3 VNTR GENOTYPES MAY PREDICT OVERALL SURVIVAL IN BLADDER CANCER PATIENTS IN THE TURKISH POPULATION

53 non-muscle invasive bladder cancer with prostatic stroma invasion: a case report and review of literature

54 sialidase neu1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and akt signaling pathway

55 how do we manage high-grade t1 bladder cancer? conservative or aggressive therapy?

56 the immediate results of surgical treatment of bladder cancer

57 saudi oncology society clinical management guidelines for urinary bladder cancer

58 study of serum level of chrome in bladder cancer patients

59 frequency of p16ink4a and p14arf genes methylation and its impact on bladder cancer cases in north indian population

60 weekly intravesical bacillus calmette-guerin (bcg) alternating with epirubicin in ta and t1 urothelial bladder cancer: an approach to decrease bcg toxicity

61 omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer

62 methylation markers for urine-based detection of bladder cancer: the next generation of urinary markers for diagnosis and surveillance of bladder cancer

63 dactilitis and oligoarthritis after bcg immunotherapy in a patient affected by bladder cancer

64 update on the management of invasive bladder cancer 2012

65 evaluation of a bladder cancer cluster in a population of criminal investigators with the bureau of alcohol, tobacco, firearms and explosives—part 2: the association of cancer risk and fire scene investigation

66 cordycepin induces s phase arrest and apoptosis in human gallbladder cancer cells

67 psca rs2294008 c > t polymorphism contributes to gastric and bladder cancer risk

68 association between the tacc3 rs798766 polymorphism and risk of urinary bladder cancer: a synthesis based on current evidence

69 a case of pott’s disease with epidural abscess and probable cerebral tuberculoma following bacillus calmette-guérin therapy for superficial bladder cancer

70 sociomedical examination of patients with urinary bladder cancer after cystectomy

71 effect of ultrasound combined with determination of ca19-9 and hs-crp on the accuracy of early diagnosis of gallbladder cancer

72 bladder cancer screening among diabetic patients on metformin therapy in a west africa subregion

73 epigenome-wide dna methylation profiling identifies differential methylation biomarkers in high-grade bladder cancer

74 mechanism research of pirarubicin postoperative immediately bladder irrigation combined compound matrine injection on treating superficial bladder cancer

75 possibilities of using radiodiagnostic methods in the staging of urinary bladder cancer and in the determination of its treatment policy

76 tsp-1-1223 a/g polymorphism as a potential predictor of the recurrence risk of bladder cancer in a chinese population

77 orthotopic ileal neobladder reconstruction for bladder cancer: is adjuvant chemotherapy safe?

78 stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer

79 preoperative serum apolipoprotein a-i levels predict long-term survival in non-muscle-invasive bladder cancer patients

80 inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment

81 potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with p-mapa and systemic administration of cisplatin and doxorubicin

82 evolution of network biomarkers from early to late stage bladder cancer samples

83 parity and risk of death from gallbladder cancer among a cohort of premenopausal parous women in taiwan

84 magnetic resonance diffusion-weighted whole-body imaging (dwibs) in the urinary bladder cancer diagnostics

85 surveillance and treatment of non-muscle-invasive bladder cancer in the usa

86 Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes.

87 [A comparative study of DNA measurement of bladder cancer from image cytometry and chromosome aberration in in situ hybridization].

88 β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation

89 WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer

90 Î²-Catenin activation synergizes with PTEN loss to cause bladder cancer formation - Oncogene

91 Intravesical BCG-Therapy for Superficial Bladder Cancer: Its Effectiveness and Adverse Effects

92 A case of portal vein thrombosis during chemotheraphy for bladder cancer

93 MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotheraphy

94 Meticulous initial clinical and pathological staging with standardized long-term follow-up after radical cystectomy is required to validate and improve overall prognostic performance in patients undergoing neoadjuvant chemotherapy for bladder cancer.

95 Mathematical Modeling of BCG-based Bladder Cancer Treatment Using Socio-Demographics

96 Mathematical Modeling of BCG-based Bladder Cancer Treatment Using Socio-Demographics

97 Redefining cystoscopy with ai: bladder cancer diagnosis using an efficient hybrid cnn-transformer model